Keyphrases
Nicotinic Acetylcholine Receptor (nAChR)
100%
Human Astrocytes
100%
PAM2
100%
Human Microglia
100%
Nicotine
66%
Glial Cells
66%
Inflammatory Mediators
50%
Astrocytes
50%
Interleukin-6
50%
Neuropathic Pain
50%
Interleukin-1β
33%
Acetylcholine Receptor (AChR)
33%
Microglia
33%
Chemokine (C-C motif) Ligand 2 (CCL2)
33%
Positive Allosteric Modulator
33%
Antinociceptive
16%
Induced Expression
16%
Spinal Cord
16%
Selective Antagonist
16%
CXCL10
16%
Health Systems
16%
Health Problems
16%
Inflammatory Pathways
16%
Work Support
16%
Anti-inflammatory Effect
16%
Economic Burden
16%
Enzyme-linked Immunosorbent Assay (ELISA)
16%
Inhibitory Effect
16%
Therapeutic Strategies
16%
Chronic Pain
16%
Inflammatory Chemokines
16%
Addictive Behavior
16%
Pain Treatment
16%
Novel Agents
16%
Methyllycaconitine
16%
Potential Therapeutic Strategies
16%
Opioid Epidemic
16%
Epidemic Crisis
16%
Sensory Aspects
16%
Non-sensory
16%
Peripheral Pain
16%
Nociceptive Behavior
16%
Tolerant Behavior
16%
Modulating Activity
16%
Central Pain
16%
Pharmacology, Toxicology and Pharmaceutical Science
Nicotinic Receptor
100%
Positive Allosteric Modulator
100%
Interleukin 6
37%
Neuropathic Pain
37%
Cholinergic Receptor
25%
Opiate
12%
Antinociception
12%
Disease
12%
Cytokine
12%
Chemokine
12%
Chronic Pain
12%
Enzyme-Linked Immunosorbent Assay
12%
Interleukin 1
12%
Cholinergic Receptor Stimulating Agent
12%
Methyllycaconitine
12%
Addiction
12%